v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities    
Net income $ 96,474 $ 44,779
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Depreciation and amortization 44,716 38,879
Amortization of debt issuance costs 84 128
Amortization of right of use assets 91 69
(Recoveries of) Provision for losses on accounts receivable, net of adjustments (62) 270
Provision for losses on contract assets, net of adjustments 0 200
Provision for excess and obsolete inventories, net of write-offs 1,225 288
Share-based compensation 10,702 8,795
Other 0 (71)
Deferred income taxes 7,823 (2,423)
Changes in assets and liabilities:    
Accounts receivable (46,314) (23,409)
Income tax receivable 8,233 (3,187)
Inventories (71,402) (47,848)
Contract assets (11,836) (97,963)
Prepaid expenses and other long-term assets 6,284 (68)
Accounts payable 63,877 36,397
Contract liabilities (67,918) 18,839
Extended warranties 7,075 (148)
Accrued liabilities and other long-term liabilities 5,916 (4,567)
Net cash provided by (used in) operating activities 54,968 (31,040)
Investing Activities    
Capital expenditures (97,282) (82,515)
Grant proceeds received 1,650 0
Proceeds from sale of property, plant and equipment 0 40
Acquisition of intangible assets (5,292) (7,042)
Principal payments from note receivable 0 25
Net cash used in investing activities (100,924) (89,492)
Financing Activities    
Borrowings of debt 597,485 415,126
Payments of debt (560,805) (252,982)
Proceeds from financing obligation, net of issuance costs 12,908 0
Payment related to financing costs (399) (1,395)
Stock options exercised 29,100 10,025
Repurchase of stock - open market 0 (29,992)
Repurchases of stock - LTIP plans (Note 17) (4,468) (9,167)
Cash dividends paid to stockholders (16,377) (16,276)
Net cash provided by financing activities 57,444 115,339
Net increase (decrease) in cash, cash equivalents, and restricted cash 11,488 (5,193)
Cash, cash equivalents, and restricted cash, beginning of period 1,239 6,514
Cash, cash equivalents, and restricted cash, end of period $ 12,727 $ 1,321